Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
[Brain metabolism in multiple sclerosis: effects of neurotrophic therapy.]
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
Revised diagnostic criteria of multiple sclerosis.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Pathogenesis of immune-mediated neuropathies.
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Contribution of symptom clusters to multiple sclerosis consequences.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Acute disseminated encephalomyelitis after treatment of Plasmodium vivax malaria.
Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Pages
« first
‹ previous
…
471
472
473
474
475
476
477
478
479
…
next ›
last »